top of page
it's where dermatology lives
By John Evans
Aug 9, 20192 min read
Number of known genetic contributors to BCC, SCC, doubled
“We compared the genetic information of patients treated for BCCs and SCCs to that from 600,000 people without these cancers—which allowed u
By John Evans
Aug 2, 20192 min read
Study of sebaceous gland stem cells reveals insights into abnormal cell growth
A study of stem cells in the development and life of sebaceous glands has shed new light into how these structures form in the skin, how the
By John Evans
Jul 5, 20192 min read
DDX3X protein linked to aggressive melanoma
“The activity of the MITF gene determines the melanoma cells’ specific characteristics, which are then linked to the disease prognosis. The
By John Evans
May 10, 20192 min read
Letters from colleagues reduce Mohs excision area, cost
A peer-to-peer performance evaluation letter successfully convinced U.S. surgeons to reduce the amount of tissue they removed during Mohs mi
By John Evans
May 3, 20192 min read
Sun protection still low in half of U.S. population
“Nearly 20 Americans die from melanoma every day,” said board-certified dermatologist and AAD president Dr. George J. Hruza, in the release.
by John Evans
Mar 29, 20192 min read
MITF identified as therapeutic target in melanoma
“When human melanoma cell lines were evaluated for growth effects using the chemical inhibitor of p300 HAT, the cell lines that were most se
by John Evans
Mar 22, 20193 min read
Calcipotriol/5-FU tx for AKs may reduce future SCC development
“This finding provides the first clinical proof-of-concept that an immunotherapy directed against premalignant tumors can prevent cancer,” s
by Bianca Quijano
Mar 11, 20192 min read
Melanoma: Single dose of PD-1 inhibitor may put patients in remission, and predict outcomes
Furthermore, investigators isolated patterns in how melanoma develops resistance to PD-1 inhibitors after surgery, which may lead to deeper
Featured Posts
bottom of page